Used in pharmaceutical research as a key intermediate in the development of kinase inhibitors, particularly targeting enzymes involved in inflammatory and oncogenic signaling pathways. Its structural features enable selective binding to ATP pockets in protein kinases, making it valuable in the design of small-molecule therapeutics for cancer and autoimmune diseases. The compound's rigid bicyclic framework and fluorinated aryl group enhance metabolic stability and target affinity, which are critical for optimizing drug potency and pharmacokinetics.